Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Roche Products Limited
Hexagon Place, 6 Falcon Way, Shire Park, Welwyn Garden City, Hertfordshire, AL7 1TW
Telephone: +44 (0)1707 366 000
Fax: +44 (0)1707 338 297
WWW: http://www.rocheuk.com
Medical Information Direct Line: +44 (0)800 328 1629
Medical Information e-mail: medinfo.uk@roche.com
Customer Care direct line: +44 (0)800 731 5711
Medical Information Fax: +44 (0)1707 384555

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 29/06/2011
PIL Xeloda 150mg Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 29/06/2011 and displayed until Current
Reasons for adding or updating:
  • Improved Electronic Presentation
  • Change to date of revision
Updated on 09/04/2010 and displayed until 29/06/2011
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to side-effects
Updated on 12/11/2008 and displayed until 09/04/2010
Reasons for adding or updating:
  • Change to side-effects
Updated on 14/04/2008 and displayed until 12/11/2008
Reasons for adding or updating:
  • Change to date of revision
Updated on 12/02/2008 and displayed until 14/04/2008
Reasons for adding or updating:
  • Change to date of revision
  • Change to Further Information section
Updated on 01/05/2007 and displayed until 12/02/2008
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 13/06/2006 and displayed until 01/05/2007
Reasons for adding or updating:
  • Change to Further Information section
Updated on 17/02/2006 and displayed until 13/06/2006
Reasons for adding or updating:
  • Change to Further Information section
  • Change to warnings or special precautions for use
  • Change to date of revision
Updated on 14/04/2005 and displayed until 17/02/2006
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to Further Information section
Updated on 14/04/2005 and displayed until 14/04/2005
Reasons for adding or updating:
  • Change to how to administer the medicine
  • Change to side-effects
  • Change to storage instructions
  • Change to date of revision
Updated on 06/07/2004 and displayed until 14/04/2005
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 03/04/2002 and displayed until 06/07/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 28/02/2001 and displayed until 03/04/2002
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
  capecitabine